Priliximab

From WikiMD.org
Jump to navigation Jump to search

Priliximab

Priliximab (pronounced: pri-lixi-mab) is a type of monoclonal antibody used in the treatment of various autoimmune diseases and cancers.

Etymology

The term "Priliximab" is derived from the International Nonproprietary Names (INN), where 'pr' signifies the drug's use in autoimmune diseases, 'lix' indicates the drug's human origin, 'i' denotes the immune system as the target, and 'mab' is the suffix for monoclonal antibodies.

Usage

Priliximab is used in the treatment of diseases where the immune system is overactive or where it attacks the body's own cells. This includes conditions such as rheumatoid arthritis, lupus, and certain types of cancer. It works by binding to specific proteins in the body, blocking their action and reducing inflammation or preventing the growth of cancer cells.

Related Terms

  • Monoclonal Antibodies: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Autoimmune Diseases: Conditions in which your immune system mistakenly attacks your body.
  • Rheumatoid Arthritis: A chronic inflammatory disorder affecting many joints, including those in the hands and feet.
  • Lupus: An inflammatory disease caused when the immune system attacks its own tissues.
  • Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski